S
66.72
-0.80 (-1.18%)
| 前收盘价格 | 67.51 |
| 收盘价格 | 67.00 |
| 成交量 | 315,816 |
| 平均成交量 (3个月) | 1,273,191 |
| 市值 | 11,574,585,344 |
| 市盈率 (P/E TTM) | 7.51 |
| 预期市盈率 (P/E Forward) | 11.36 |
| 价格/销量 (P/S) | 1.56 |
| 股市价格/股市净资产 (P/B) | 2.56 |
| 52周波幅 | |
| 利润日期 | 5 May 2026 |
| 营业毛利率 | 4.56% |
| 营业利益率 (TTM) | 7.73% |
| 稀释每股收益 (EPS TTM) | 2.17 |
| 季度收入增长率 (YOY) | 2.70% |
| 季度盈利增长率 (YOY) | -42.20% |
| 总债务/股东权益 (D/E MRQ) | 242.58% |
| 流动比率 (MRQ) | 1.19 |
| 营业现金流 (OCF TTM) | 772.00 M |
| 杠杆自由现金流 (LFCF TTM) | 1.05 B |
| 资产报酬率 (ROA TTM) | 3.72% |
| 股东权益报酬率 (ROE TTM) | 10.66% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 混合的 | 看跌 | |
| 股票 | Solventum Corporation | 看涨 | 看涨 |
AIStockmoo 评分
2.4
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | 1.5 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 2.38 |
|
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Core |
| 内部持股比例 | 20.00% |
| 机构持股比例 | 67.75% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 100.00 (BTIG, 49.89%) | 购买 |
| 中 | 99.00 (48.39%) | |
| 低 | 83.00 (Wells Fargo, 24.41%) | 保留 |
| 平均值 | 94.00 (40.90%) | |
| 总计 | 2 购买, 1 保留 | |
| 平均价格@调整类型 | 74.20 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BTIG | 27 Feb 2026 | 100.00 (49.89%) | 购买 | 74.20 |
| Keybanc | 27 Feb 2026 | 99.00 (48.39%) | 购买 | 74.20 |
| Wells Fargo | 27 Feb 2026 | 83.00 (24.41%) | 保留 | 74.20 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| ALBAN CARLOS | - | - | 0 | 0 |
| COX CARRIE SMITH | - | - | 0 | 0 |
| DEVORE SUSAN D. | - | - | 0 | 0 |
| EDWARDS SHIRLEY ANN | - | - | 0 | 0 |
| EISENBERG GLENN A | - | - | 0 | 0 |
| HARRIS BERNARD A JR | - | - | 0 | 0 |
| MAY KAREN J | - | - | 0 | 0 |
| MILY ELIZABETH | - | - | 0 | 0 |
| WEILAND JOHN H | - | - | 0 | 0 |
| WENDELL AMY MCBRIDE | - | - | 0 | 0 |
| WILSON DARRYL L. | - | - | 0 | 0 |
| 累积净数量 | 0 | |||
| 累积净值 ($) | 0 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| ALBAN CARLOS | 董事 | 30 Apr 2026 | 执行期权 | 3,403 | - | - |
| COX CARRIE SMITH | 董事 | 30 Apr 2026 | 执行期权 | 4,916 | - | - |
| DEVORE SUSAN D. | 董事 | 30 Apr 2026 | 执行期权 | 3,403 | - | - |
| EDWARDS SHIRLEY ANN | 董事 | 30 Apr 2026 | 执行期权 | 3,403 | - | - |
| EISENBERG GLENN A | 董事 | 30 Apr 2026 | 执行期权 | 3,403 | - | - |
| HARRIS BERNARD A JR | 董事 | 30 Apr 2026 | 执行期权 | 3,403 | - | - |
| MAY KAREN J | 董事 | 30 Apr 2026 | 执行期权 | 3,403 | - | - |
| WILSON DARRYL L. | 董事 | 30 Apr 2026 | 执行期权 | 3,403 | - | - |
| MILY ELIZABETH | 董事 | 30 Apr 2026 | 执行期权 | 3,403 | - | - |
| WEILAND JOHN H | 董事 | 30 Apr 2026 | 执行期权 | 3,403 | - | - |
| WENDELL AMY MCBRIDE | 董事 | 30 Apr 2026 | 执行期权 | 3,403 | - | - |
| 显示更多 | ||||||
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合